Pubblicazioni

Eptinezumab for the treatment of migraine

2021 - EXPERT OPINION ON BIOLOGICAL THERAPY

Spuntarelli, V.; Negro, A.; Luciani, M.; Bentivegna, E.; Martelletti, P.

What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian chronic migraine group

2020 - EXPERT REVIEW OF NEUROTHERAPEUTICS

Sacco, S.; Russo, A.; Geppetti, P.; Grazzi, L.; Negro, A.; Tassorelli, C.; Tedeschi, G.; Martelletti, P.

Optimizing the long-term management of chronic migraine with onabotulinumtoxinA in real life

2018 - EXPERT REVIEW OF NEUROTHERAPEUTICS

Tassorelli, Cristina; Tedeschi, Gioacchino; Sarchielli, P; Pini, Luigi Alberto; Grazzi, Licia; Geppetti, Pierangelo; De Tommaso, Marina; Aguggia, Marco; Cortelli, P; Martelletti, Paolo

Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age. Overview from European Medicines Agency and European Headache Federation

2018 - THE JOURNAL OF HEADACHE AND PAIN

Vatzaki, Efstratia; Straus, Sabine; Dogne, Jean-Michel; Garcia Burgos, Juan; Girard, Thomas; Martelletti, Paolo

Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers

2017 - THE JOURNAL OF HEADACHE AND PAIN

Tassorelli, Cristina; Aguggia, Marco; DE TOMMASO, Marina; Geppetti, Pierangelo; Grazzi, Licia; Pini, Luigi Alberto; Sarchielli, Paola; Tedeschi, Gioacchino; Martelletti, Paolo; Cortelli, Pietro

Chronic migraine treatment. from OnabotulinumtoxinA onwards

2016 - EXPERT REVIEW OF NEUROTHERAPEUTICS

Negro, Andrea; Curto, Martina; Lionetto, Luana; Giamberardino, Maria Adele; Martelletti, Paolo

Anti-CGRP monoclonal antibodies in migraine. current perspectives

2016 - INTERNAL AND EMERGENCY MEDICINE

Giamberardino, Maria Adele; Affaitati, Giannapia; Curto, Martina; Negro, Andrea; Costantini, Raffaele; Martelletti, Paolo